β-L-Idopyranose, 1,6-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-[(1R)-1-hydroxyethyl]-

Request For Quotation
β-L-Idopyranose, 1,6-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-[(1R)-1-hydroxyethyl]- Basic information
Product Name:β-L-Idopyranose, 1,6-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-[(1R)-1-hydroxyethyl]-
Synonyms:β-L-Idopyranose, 1,6-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-[(1R)-1-hydroxyethyl]-;Olorigliflozin
CAS:2035989-50-3
MF:C23H27ClO7
MW:450.91
EINECS:
Product Categories:
Mol File:2035989-50-3.mol
β-L-Idopyranose, 1,6-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-[(1R)-1-hydroxyethyl]- Structure
β-L-Idopyranose, 1,6-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-[(1R)-1-hydroxyethyl]- Chemical Properties
Boiling point 631.6±55.0 °C(Predicted)
density 1.432±0.06 g/cm3(Predicted)
pka13.11±0.70(Predicted)
Safety Information
MSDS Information
β-L-Idopyranose, 1,6-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-[(1R)-1-hydroxyethyl]- Usage And Synthesis
UsesOlorigliflozin is a sodium glucose co-transporter inhibitor with anti-hyperglycemic effects[1].
References[1] World Health Organization. WHO Drug Information: Volume 38[M]. World Health Organization, 2024.
β-L-Idopyranose, 1,6-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-[(1R)-1-hydroxyethyl]- Preparation Products And Raw materials
Tag:β-L-Idopyranose, 1,6-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-[(1R)-1-hydroxyethyl]-(2035989-50-3) Related Product Information
(3R,4S,5R,6R)-6-(acetoxyMethyl)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-2-hydroxytetrahydro-2H-pyran-3,4,5-triyl triacetate (2S,3R,4S,5S,6R)-2-(4-chloro-3-(4-hydroxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol (2S,3R,4S,5R,6R)-6-(acetoxymethyl)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-2-(((2R,3R,4R,5S,6S)-3,4,5-triacetoxy-6-(4-chloro-3-(4-ethoxybenzyl)phenyl)tetrahydro-2H-pyran-2-yl)methoxy)tetrahydro-2H-pyran-3,4,5-triyl triacetate Ertugliflozin-Acid Impurity Empagliflozin Impurity D SOTA-009